151. Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion
- Author
-
Michael Graef, Birgit Lorenz, Manfred Kaps, Frank Weinand, Christian Tanislav, Max Nedelmann, and Klaus-Heiko Wassill
- Subjects
Male ,medicine.medical_specialty ,Retinal Artery Occlusion ,medicine.medical_treatment ,Medicine ,Humans ,Thrombolytic Therapy ,Embolization ,Prospective Studies ,Ultrasonography, Doppler, Color ,Prospective cohort study ,Aged ,Advanced and Specialized Nursing ,Aged, 80 and over ,business.industry ,Ultrasound ,Thrombolysis ,Middle Aged ,medicine.disease ,Treatment Outcome ,Etiology ,Central retinal artery occlusion ,Female ,Neurology (clinical) ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Vasculitis ,Follow-Up Studies - Abstract
Background and Purpose— Transorbital sonography may help establish diagnosis of central retinal artery occlusion (CRAO). Next to Doppler sonographic proof of CRAO, an intra-arterial spot sign can be detected in some cases. We hypothesized that it reflects calcified components. It may be associated with embolization from atherosclerotic plaques and may negatively influence thrombolysis. Methods— Prospective monocenter study of 46 patients with ophthalmologically confirmed CRAO. Systemic tissue-type plasminogen activator thrombolysis was performed when appropriate. All patients received etiologic workup. Results— CRAO was confirmed by Doppler in all patients. Fifty-nine percent of patients with arterio-arterial embolization were spot sign–positive compared with 20% from cardiac source ( P P Conclusions— Transbulbar ultrasound is valuable for initial diagnosis and diagnostic workup of CRAO. In the light of inconsistent results of previous thrombolysis trials, ultrasound may identify patients more likely to benefit from thrombolytic treatment.
- Published
- 2015